Sentence examples for toxicity in the case of from inspiring English sources
Therefore, it was exceptionally important to estimate their toxicity in the case of a 100% bioavailability, namely, in experiments with their intravenous injection to experimental animals.
Purpose: Using a radioactive solution-filled catheter for intravascular irradiation has the potential problem of chemical and radiological toxicity in the case of a balloon rupture.
The GI data suggests that direct application of compost bio-wash without dilutions showed high level of toxicity in the case of CYV and CYP and this may be attributed to the high EC of the composts.
These endpoints were acute Daphnia and fish toxicity in the case of fungicidal combination products as well as growth inhibition of aquatic primary producers in the case of herbicidal combination products.
The material was designed to eliminate the defects of low fracture toughness in the case of ceramics and of degradation and toxicity in the case of metals when used in artificial joints.
In contrast to the LPS-induced shock, we found no difference in survival and bacterial load in the spleen after i.v. challenge of wildtype and cIAP-1 KO mice with Salmonella Typhimurium SL1344 (Fig. S4), suggesting that additional mechanisms besides endotoxin exposure cause toxicity in the case of Salmonella infection.
A more thorough comparative investigation of the toxicity threat in the case of larger-size 0.4 kWh Li-ion modules was thus undertaken.
Formulation additives are suspected to be the reason for unexpected high product toxicity particularly in the case of products where the tested organisms are rather insensitive for the a.s contained in the product such as for example fish in the case of specifically acting herbicides.
Zinc sulfate and D-penicillamine (D-PCA) have both proved to be clinically effective in the treatment of WD, but zinc sulfate offers the advantage of having a very low toxicity, especially in the case of neurological involvement.
In addition, pentavalent antimonials are associated with important toxicity and, in the case of VL, with significantly high death rate, especially in some sub-groups of patients: severely ill, > 45 years, HIV co-infected.
Current methods for transcriptional repression and activation such as RNAi and other DNA binding proteins, ZFN and TALEN, harbored significant shortcomings such as off-target effects, toxicity, and in the case of ZFN and TALEN proteins, difficulty with design and implementation.
